Treatment of Mycobacterium abscessus : All Macrolides Are Equal, but Perhaps Some Are More Equal than Others
Authors:
- 1 November 2012
- journal article
- editorial
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 186 (9) , 822-823
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massiliense Infection and Inducible ResistanceAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary DiseaseClinical Infectious Diseases, 2011
- Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessusAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria InfectionsEmerging Infectious Diseases, 2010
- Nontuberculous Mycobacterial Lung Disease Prevalence at Four Integrated Health Care Delivery SystemsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Host Immune Response to Rapidly Growing Mycobacteria, an Emerging Cause of Chronic Lung DiseaseAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Increasing Incidence of Nontuberculous Mycobacteria, Taiwan, 2000–2008Emerging Infectious Diseases, 2010
- A Novel Gene,erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates ofMycobacterium abscessusbut Is Absent fromMycobacterium chelonaeAntimicrobial Agents and Chemotherapy, 2009
- An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Ancestral antibiotic resistance in Mycobacterium tuberculosisProceedings of the National Academy of Sciences, 2005